These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 16887487

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rituximab plus CHOP for diffuse large-B-cell lymphoma.
    Akhtar S, Maghfoor I.
    N Engl J Med; 2002 Jun 06; 346(23):1830-1; author reply 1830-1. PubMed ID: 12050349
    [No Abstract] [Full Text] [Related]

  • 3. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ, Zhang QY, Chen DF, Guan XJ, Zhang BL, Ma J.
    Ai Zheng; 2005 Dec 06; 24(12):1498-502. PubMed ID: 16351800
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Indolent lymphoma: can rituximab resolve the watch-and-wait debate?
    Ross E.
    J Natl Cancer Inst; 2010 Feb 24; 102(4):220-1. PubMed ID: 20145214
    [No Abstract] [Full Text] [Related]

  • 8. Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma.
    Miles SA, McGratten M.
    J Clin Oncol; 2005 Jan 01; 23(1):247-8. PubMed ID: 15625386
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CHOP and rituximab in elderly patients.
    Portlock CS.
    Curr Oncol Rep; 2002 Sep 01; 4(5):414. PubMed ID: 12162916
    [No Abstract] [Full Text] [Related]

  • 11. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
    Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E, Reiser M, Nickenig C, Clemens M, Peter N, Bokemeyer C, Eimermacher H, Ho A, Hoffmann M, Mertelsmann R, Trümper L, Balleisen L, Liersch R, Metzner B, Hartmann F, Glass B, Poeschel V, Schmitz N, Ruebe C, Feller AC, Loeffler M, German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
    Lancet Oncol; 2008 Feb 01; 9(2):105-16. PubMed ID: 18226581
    [Abstract] [Full Text] [Related]

  • 12. Aggressive lymphoma: improving treatment outcome with rituximab.
    Coiffier B, Pfreundschuh M, Stahel R, Vose J, Zinzani PL.
    Anticancer Drugs; 2002 Nov 01; 13 Suppl 2():S43-50. PubMed ID: 12710590
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R, Hagenbeek A.
    Eur J Haematol Suppl; 2007 Jan 01; (67):5-14. PubMed ID: 17206982
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rituximab in the treatment of diffuse large B-cell lymphomas.
    Coiffier B.
    Semin Oncol; 2002 Feb 01; 29(1 Suppl 2):30-5. PubMed ID: 11842386
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dose-dense CHOP plus rituximab (R-CHOP14) for the treatment of elderly patients with high-risk diffuse large B cell lymphoma: a pilot study.
    Rigacci L, Nassi L, Alterini R, Carrai V, Longo G, Bernardi F, Martini V, Bosi A.
    Acta Haematol; 2006 Feb 01; 115(1-2):22-7. PubMed ID: 16424645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.